RxDoctor Payments Data

Michael Busby, PA

Physician Assistant · Milton, FLNPI 1962462671

Payments from drug & device makers

$1,649in general payments, 2019–2025

Across 99 payments — averaging $16.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$311
  • GSK$240
  • Lilly USA, LLC$192
  • Pfizer$141
  • Dexcom, Inc.$139
  • Boehringer Ingelheim$97
  • plus $530 from 12 others

What the payments were for

  • Food & beverage$1,649100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,649 in reported general payments places this provider in the 70th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$208
Medicare patients
12
Services billed
14

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$51,953
TrulicityDulaglutide39$48,402
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$35,919
EliquisApixaban22$22,986
FarxigaDapagliflozin Propanediol14$19,388
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$18,265
TradjentaLinagliptin13$16,041
GlyxambiEmpagliflozin/Linagliptin11$10,012
Albuterol Sulfate HfaAlbuterol Sulfate117$5,817
Gabapentin132$2,967
Omeprazole153$2,852
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,170
Ventolin HfaAlbuterol Sulfate29$2,005
Atorvastatin Calcium239$1,696
Tramadol Hcl159$1,413

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$52$51,95339 claims
Lilly USA, LLCTrulicity$192$48,40239 claims
AstraZenecaFarxiga, Breztri Aerosphere$72$37,65232 claims
GSKTrelegy Ellipta$240$35,91935 claims
Boehringer IngelheimTradjenta, Glyxambi$97$26,05424 claims
PfizerEliquis$141$22,98622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Milton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →